|
HLA
typing of tumor cell lines and PBMC obtained from normal blood
donors.
|
Cell
line
|
Locusa
|
|
A
|
B
|
C
|
DR
|
DQ
|
|
Tumor
cell lines
|
|
PCI-13
|
2, 3
|
7, 35
|
w12, w15
|
4(0401),
7(0701)
|
w2, w3
|
|
PCI-1
|
2, 3
|
7, 39
|
4, 7
|
53
|
2, 8
|
|
PCI-30
|
2, 28
|
49, 53
|
ND
|
2, 5
|
w1, w3
|
|
OSC-19
|
2
|
7
|
7
|
1
|
5
|
|
PCI-23
|
1
|
8, 44
|
ND
|
3, 7
|
w2
|
|
PCI-4B
|
24, 26
|
35, 44
|
w4, w14
|
1, 3
|
w3
|
|
SCC-74
|
33
|
15, 51
|
4, 16
|
1, 13
|
6
|
|
HR
(Adeno, CA)
|
1, 2
|
8, w56
|
ND
|
3
|
ND
|
|
MEL526
|
2, 3
|
50, 62
|
ND
|
ND
|
ND
|
|
T2
|
2
|
-
|
-
|
-
|
-
|
|
CTL
lines established from PBMCs of normal donors
|
|
CTL-DC#1
|
1, 2
|
8, 35
|
|
|
|
|
CTL-DC#2
|
1, 2
|
44, 55
|
6
|
|
|
|
CTL-DC#3
|
2, 32
|
44, 50
|
5, 6
|
|
|
aND, not determined.
|
